Scientists identify conserved genetic switch controlling tendon and ligament development

Tendons and ligaments are among the body's most stubborn tissues to repair. Once damaged, they heal poorly—if they heal at all. The reason is simple: they lack the blood supply that other tissues rely on to mend themselves. An international research team has now identified why these tissues form the way they do in the first place, a discovery that could eventually unlock new ways to regenerate them after injury.

The team, led by Professor Chisa Shukunami at Hiroshima University, published their findings in the journal Development. They traced the molecular origins of tendon and ligament formation to a genetic switch—a stretch of DNA called an enhancer—that controls when and where a crucial gene called Scleraxis gets turned on. Enhancers are regulatory sequences that act like dimmer switches for genes, determining not just whether a gene activates, but precisely when and in which tissues it does so. The researchers identified a 343-base-pair segment of this enhancer that has remained virtually unchanged across hundreds of millions of years of evolution, preserved from lobe-finned fishes through to humans.

To find this enhancer, the team used transgenic mice engineered to glow when specific DNA sequences became active. This allowed them to watch, in real time, where Scleraxis gene expression occurred during limb development. They discovered a larger enhancer region spanning 5.3 kilobases, and within it, the smaller conserved segment that proved essential. The fact that this sequence has been conserved from coelacanths to people suggests it performs a fundamental job that evolution has deemed too important to tinker with.

When the researchers deleted this conserved enhancer from mice using genome editing, the consequences were striking. The animals showed a sharp drop in Scleraxis expression during early limb development and failed to form the deltoid tuberosity—a bony ridge on the upper arm where the deltoid muscle attaches to the humerus. This ridge is essential for normal shoulder movement. The mice's bodies could not build this structure properly without the enhancer's signal at the critical moment when limbs were forming. Interestingly, Scleraxis expression recovered somewhat later in development, suggesting that other regulatory regions within the larger enhancer could partially compensate, but only after the damage was done.

The significance of this work extends beyond basic biology. Tendons, ligaments, and their attachment points to bone—called entheses—are notoriously difficult to repair because they receive so little blood flow. When these tissues tear or degenerate, patients often face chronic pain and loss of function. Understanding how Scleraxis controls their formation is a necessary first step toward coaxing the body to rebuild them. Shukunami emphasized that the team's goal is to use this knowledge as a foundation for regenerative medicine, the field devoted to repairing or replacing damaged tissues and organs.

The researchers are already planning their next moves. They intend to map out the full network of genetic regulators that control Scleraxis expression, working toward identifying the master switches that orchestrate the entire process of musculoskeletal integration. If they succeed, they may eventually be able to reactivate the same developmental programs in adults, potentially allowing tendons and ligaments to heal themselves the way they do during fetal development. For now, they have provided what Shukunami calls an important foothold—a concrete molecular target that researchers worldwide can build upon.